SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

(HealthDay News) — Loosening restrictions on short-term limited duration (STLD) insurance plans, many of which do not cover essential health benefits such as cancer screening, yields an increase in ...

(HealthDay News) — Food insecurity is associated with incident cardiovascular disease (CVD) events, even when adjusting for sociodemographic factors, according to a study published online in JAMA ...

Survey respondents preferred patient portal messages written by AI, but their satisfaction decreased when they were told that messages were written by AI.

(HealthDay News) — Microplastics appear to be present in filtered solutions used for medical intravenous infusions, with about 7500 particles/L found in infusion solutions from polypropylene (PP) ...

Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers ...

Short-term ADT especially benefitted patients with a baseline PSA level of more than 2 ng/mL, a PSA doubling time of less than 3 months, and a higher metastatic stage, presumably because they were ...

Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Association with oral cavity cancer stronger when restricted to nonsmokers or light smokers and nondrinkers and light drinkers ...

The US Department of Veterans Affairs (VA) has announced it will no longer provide hormone therapy to veterans newly diagnosed with gender dysphoria. The decision follows an executive order from ...

(HealthDay News) — Children with congenital heart disease (CHD) have increased risk of developing cancer, according to a research letter published in Circulation.

In recent study, 9% of participants taking placebo developed COVID-19 versus 2.9% of people taking ensitrelvir ...